![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmÃnticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário 14 May 2012 12:40:42
Markets drop on rising inflationMarkets drop on rising inflation Business Standard Lupin rallied 4.4% to Rs 544 in otherwise weak market in noon deals, on reports that the drug maker is expected to soon launch its generic version of the anti-HIV drug, Combivir , in the United States. The broader markets underperformed the benchmark ...
14 May 2012 05:47:38
Indian stocks to watch-May 14Indian stocks to watch-May 14 Reuters (Economic Times) Drug maker Lupin Ltd is expected to soon launch its generic version of the anti-HIV drug, Combivir , in the United States. (Business Standard) Top representatives of various industry bodies and other stakeholders will get a chance ...
13 May 2012 21:02:12
Lupin set to launch anti-AIDS generic drug in the USLupin set to launch anti-AIDS generic drug in the US Business Standard Drug maker Lupin Ltd is expected to soon launch its generic version of the anti-HIV drug, Combivir , in the United States. The move was likely to lend a significant upside to the Mumbai-based company's bottom line in the forthcoming quarters, ...
28 Apr 2012 09:15:55
This Day in History - April 28This Day in History - April 28 Jamaica Observer 2003 - Britain's GlaxoSmithKline PLC, the world's largest producer of AIDS drugs, announces it will reduce the price of its popular AIDS medication Combivir to 90 cents a day, from US$1.70, in 63 developing countries. 2004: Macedonia's liberal prime ...
26 Apr 2012 13:24:09
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ...Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... MarketWatch (press release) Some major patent expiries are expected during the forecast period, such as for Sustiva, Combivir , Tenofovir, Telbivudine, Tamiflu and Relenza (by 2017). The patent expiries of these blockbuster drugs will trigger generic competition in the antivirals ...
26 Apr 2012 12:52:09
GlaxoSmithKline net profit dips by 12% in Q1GlaxoSmithKline net profit dips by 12% in Q1 pharmabiz.com ViV Healthcare turnover declined by 5 per cent as the effect of recent launches of generic competitors in the US to Combivir and Epivir offset the growth of newer products. Andrew Witty, CEO, said, â We remain mindful of the challenges we face given the ...
25 Apr 2012 13:53:02
Pro Generika kritisiert KKH-Allianz-Ausschreibung DAZ.online Pro Generika kritisiert KKH-Allianz-Ausschreibung DAZ.online Die KKH-Allianz hat aktuell zehn patentgeschà tzte Wirkstoffe ausgeschrieben, unter denen sich auch die Wirkstoffkombination aus Lamivudin und Zidovudin ( Combivir  ) befindet. Der Branchenverband Pro Generika sieht dies kritisch: Obwohl der Ablauf des ... Pro Generika zur aktuellen Ausschreibung der KKH-Allianz: KKH-Allianz setzt ... |
|
Choose Your language:
Pesquisa no site:
Testemunhos
Recebi a encomenda atempadamente e os comprimidos são óptimos. A minha mulher agradece. Agradeço eu, agradecem também a cama, o quarto, os lençóis etc.... - Mark
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Mais vendidos|Política|Questões Mais Frequentes|Testemunhos|Contacte-nos|Sitemap |
|
|
|
|
| |